Sign in to view content

Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study

Peter K. Kaiser, MD FASRS

Video
Published 2019

Peter K. Kaiser, MD

AMD Non-neovascular Symposium

Related

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019
Development of a Novel Retinal Tamponade Agent to Replace Fluorinated Gas and Silicone Oil
James A Stefater, MD, PhD
Annual Meeting Talks
2019
Elamipretide, a Mitochondrial-Targeted Drug, for the Treatment of Vision Loss in Dry AMD with High Risk Drusen
Michael J Allingham, MD, PhD
Annual Meeting Talks
2019

Category: AMD-Non-Neovascular

See more